Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis

Published:2019-05-31 Issue:7 Volume:19 Page:617-630
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Ennis Daniel¹,Lee Jason Kihyuk²,Pagnoux Christian¹³

Affiliation:

1. Vasculitis Clinic, Division of Rheumatology, Mount Sinai Hospital, University Health Network, Toronto, Canada

2. Division of Rheumatology, Mount Sinai Hospital, University Health Network, Toronto Allergy and Asthma Clinic, Toronto, Canada

3. Division of Rheumatology, Mount Sinai Hospital, University Health Network, Canadian Vasculitis research network (CanVasc), Toronto, Canada

Funder

not funded

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2019.1623875

Reference151 articles.

1. Allergic granulomatosis

2. Nomenclature of Systemic Vasculitides

3. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

4. Eosinophilic granulomatosis with polyangiitis (Churg–Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidencia terapéutica del mepolizumab en la granulomatosis eosinofílica con poliangeítis: una revisión exploratoria;Revista Colombiana de Reumatología;2024-02

2. Long-term mepolizumab treatment reduces relapse rates in super-responders with eosinophilic granulomatosis with polyangiitis;Allergy, Asthma & Clinical Immunology;2023-05-13

3. Long-term treatment by mepolizumab reduces the relapse rate in patients with eosinophilic granulomatosis with polyangiitis;2023-02-08

4. Updates in ANCA-associated vasculitis;European Journal of Rheumatology;2022-08-15

5. Recent Advancements in the Management of Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Systematic Review;Cureus;2022-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3